Industry Insights | D2R & HDT Bio скачать в хорошем качестве

Industry Insights | D2R & HDT Bio

Featuring Jesse Erasmus, Director of Virology at HDT Bio, this hybrid seminar introduced HDT’s innovative RNA-based technology platform. Hosted by D2R, the event aimed to explore potential collaborations with Canadian researchers in the fields of oncology and infectious diseases. The presentation highlighted HDT Bio’s cutting-edge work at the intersection of RNA therapeutics and immunology, showcasing platform technologies with broad applications across multiple disease areas. --------------- D2R (DNA to RNA) is a research initiative at McGill that is positioning Canada as a global leader in RNA-based therapies, revolutionizing treatments for rare and infectious diseases, and cancer. With a landmark $165 million investment from the Government of Canada, D2R is advancing cutting-edge science and building powerful collaborations across academia, industry, and different communities to ensure that life-saving therapies are accessible to all, especially equity-deserving populations. --------------- WEBSITE: https://www.mcgill.ca/dna-to-rna/ TWITTER/X: https://x.com/D2RMcGill BLUESKY: https://bsky.app/profile/d2rmcgill.bs... LINKED IN:   / d2r-dna-to-rna